You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Some of the firms will receive money to speed up test development, while others will use the funds to expand their testing and manufacturing capacity.
The commercial labs will also receive testing equipment from Beckman Coulter Life Sciences and Thermo Fisher Scientific including RT-PCR instrumentation.
Under the new 15-year exclusive agreement, the test will become available through all of Sonic's clinical labs and anatomic pathology practices in the US.
The PGx decision support software that Sonic is adopting includes clinical reporting for 65 genes and can be tailored to a variety of clinical specialties.
Changes to Medicare reimbursements are forcing hospitals to create lab-focused joint ventures and partner in various ways with other organizations to stay financially viable.
The test was developed by the University of Pittsburgh Medical Center and is marketed in partnership with Sonic Healthcare.
The test screens for 90 mutations across 29 oncogenes and analyzes eight exons of three genes to help clinicians select treatments.
NEW YORK (GenomeWeb News) – Ariosa Diagnostics today said that it has inked a deal with a subsidiary of Sonic Healthcare to offer the firm's Harmony Prenatal Test in Germany.
NEW YORK (GenomeWeb News) – Genetic Technologies today announced it has settled with a group of companies associated with Sonic Healthcare over a patent infringement lawsuit.
The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.
The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.
Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.
In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.